» Articles » PMID: 37921621

ACVIM Consensus Statement on the Management of Status Epilepticus and Cluster Seizures in Dogs and Cats

Overview
Date 2023 Nov 3
PMID 37921621
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Seizure emergencies (ie, status epilepticus [SE] and cluster seizures [CS]), are common challenging disorders with complex pathophysiology, rapidly progressive drug-resistant and self-sustaining character, and high morbidity and mortality. Current treatment approaches are characterized by considerable variations, but official guidelines are lacking.

Objectives: To establish evidence-based guidelines and an agreement among board-certified specialists for the appropriate management of SE and CS in dogs and cats.

Animals: None.

Materials And Methods: A panel of 5 specialists was formed to assess and summarize evidence in the peer-reviewed literature with the aim to establish consensus clinical recommendations. Evidence from veterinary pharmacokinetic studies, basic research, and human medicine also was used to support the panel's recommendations, especially for the interventions where veterinary clinical evidence was lacking.

Results: The majority of the evidence was on the first-line management (ie, benzodiazepines and their various administration routes) in both species. Overall, there was less evidence available on the management of emergency seizure disorders in cats in contrast to dogs. Most recommendations made by the panel were supported by a combination of a moderate level of veterinary clinical evidence and pharmacokinetic data as well as studies in humans and basic research studies.

Conclusions And Clinical Relevance: Successful management of seizure emergencies should include an early, rapid, and stage-based treatment approach consisting of interventions with moderate to preferably high ACVIM recommendations; management of complications and underlying causes related to seizure emergencies should accompany antiseizure medications.

Citing Articles

Electroencephalographic Features of Presumed Hepatic Encephalopathy in a Pediatric Dog with a Portosystemic Shunt-A Case Report.

Stefanescu R, Boghian V, Solcan G, Codreanu M, Musteata M Life (Basel). 2025; 15(1).

PMID: 39860047 PMC: 11767108. DOI: 10.3390/life15010107.


Phenotypic characterization and quality of life of Labradoodles with idiopathic epilepsy and epilepsy of unknown cause.

Mandigers P, Meijs S, Plonek M, Santifort K, Diaz Espineira M Front Vet Sci. 2024; 11:1459260.

PMID: 39479204 PMC: 11523295. DOI: 10.3389/fvets.2024.1459260.


Evaluation of Blood C Reactive Protein (CRP) and Neutrophil-to-Lymphocyte Ratio (NLR) Utility in Canine Epilepsy.

Despa A, Musteata M, Solcan G Vet Sci. 2024; 11(9).

PMID: 39330787 PMC: 11436050. DOI: 10.3390/vetsci11090408.


Efficacy and safety of alfaxalone compared to propofol in canine refractory status epilepticus: a pilot study.

Al Kafaji T, Corda A, Charalambous M, Murgia E, Tartari I, Puci M Front Vet Sci. 2024; 11:1383439.

PMID: 39040816 PMC: 11260799. DOI: 10.3389/fvets.2024.1383439.


Emergency Approach to Acute Seizures in Dogs and Cats.

Munguia G, Brooks A, Thomovsky S, Thomovsky E, Rincon A, Johnson P Vet Sci. 2024; 11(6).

PMID: 38922024 PMC: 11209469. DOI: 10.3390/vetsci11060277.


References
1.
Fisher R, Bartfeld E, Cramer J . Use of an online epilepsy diary to characterize repetitive seizures. Epilepsy Behav. 2015; 47:66-71. DOI: 10.1016/j.yebeh.2015.04.022. View

2.
Prabhakar H, Kalaivani M . Propofol versus thiopental sodium for the treatment of refractory status epilepticus. Cochrane Database Syst Rev. 2017; 2:CD009202. PMC: 6464235. DOI: 10.1002/14651858.CD009202.pub4. View

3.
Hardy B, Patterson E, Cloyd J, Hardy R, Leppik I . Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs. J Vet Intern Med. 2012; 26(2):334-40. DOI: 10.1111/j.1939-1676.2011.00868.x. View

4.
Matthews N, Brown R, Barling K, Lovering S, Herrig B . Repetitive propofol administration in dogs and cats. J Am Anim Hosp Assoc. 2004; 40(4):255-60. DOI: 10.5326/0400255. View

5.
Bruun D, Ma B, Chen Y, Wu C, Aleman M, Zolkowska D . Tolerability and pharmacokinetics of intravenous allopregnanolone with and without midazolam pretreatment in two healthy dogs. Epilepsia Open. 2023; 8(2):666-672. PMC: 10235566. DOI: 10.1002/epi4.12723. View